Archive for the ‘Tech’ category

The Epic Epoch, Cont’d

March 10, 2021

Ya got me. I haven’t updated my story archive in the longest time. But a Wisconsin State Journal story detailing Epic employee unrest related to equity and diversity got me off my keister.

For the October 2020 issue of Madison Magazine, I examined the staff unrest at the Verona-based Electronic Health Record behemoth and considered what the future might hold for Dane County’s largest private employer. You can read the story here. Here’ what I concluded:

I did not speak to a single health care source who felt Epic’s EHR dominance was in danger now or in the immediate future or even 10 years from now.

Epic’s bond with its clients is just too strong. And even if there are unhappy campers, dumping Epic would mean repudiating a huge investment. The Kaiser Permanente consortium spent a reported $4 billion implementing Epic’s software. The Mayo Clinic got in for $1.5 billion. The Duke University Health System for $700 million. Eight- and nine-figure acquisition fees are common for Epic clients.

How do you walk away from that? Especially when no other EHR vendor offers a major hospital “50 different modules for 50 different departments” as good as Epic’s, as Bluetree’s Schwach told me.

Well, it could happen if you follow John Neis’ worried thinking: Failure is an option.

Neis, who has been doing early-stage health care investing since the mid-1980s, quietly argues that Epic is not invulnerable. He says the core problem remains: EHRs are an imperfect solution. Doctors find them “soul crushing.” This dysfunction haunts health care.

“The cost of leaving Epic for something else is enormous,” Neis acknowledges. But “switching does happen.” And sometimes outright revolutions happen in technology, too. Seared in Neis’ memory is a long-ago conversation in Rochester, New York, with a clueless Kodak executive who confidently told him that digital photography would never replace film.

Neis argues that a tech company with unlimited resources could blow up the existing EHR model and build a far better one. He feels “the Three As” — Amazon, Apple and Alphabet’s Google, all well practiced in disrupting entrenched industries — are the most likely Epic challengers.

Could they afford to spend a billion or two devising a “leapfrog” EHR that both pleases doctors and improves their diagnostic skills with data-crunched insights? We both laugh at the absurdity of the question; $2 billion is coffee money for the tech giants.

“The challengers would need to spend serious money,” he says. “It can’t be just for some incremental improvement. It has to be a huge leap forward in both data analysis to help guide the physician to the right decisions and secondly to greatly improve the software’s interface with the physician.”

At this point, Neis offers — practically in a stage whisper over the phone — an unexpected fourth candidate for disrupting the existing EHR hegemony: the Epic team itself. No one is better situated to lead the transformation, he says. They know the customer better than anybody. They understand what the problems are. They get how complex the solution needs to be. And because Epic is private, it doesn’t have to worry about Wall Street freaking out over a bad quarter or two.

Neis’ advice: “Epic should figure out the transformation before someone else does.”

Will the post-Faulkner Epic be agile enough to reimagine its business?

That’s the cosmic question. Northwestern’s Jennifer Pendergast, who directs the John L. Ward Center for Family Enterprises at Kellogg School of Management, knows little about Epic’s operation but is very familiar with strong-willed founders like Faulkner.

“Are they kidding themselves to think they can control the future from the grave? Yes. Often to great detriment,” she says. “The goal is to be flexible, resilient, to be able to pivot given the current environment. What you want is an organization that has the capacity to think and adjust on its own.”

As for an organization that is tightly fit to its market, Pendergast says it “will be really successful until the business environment changes. And then you’ve got a problem.”

Advertisement

UW Fireworks Over Sponsored Research

December 16, 2018

Here’s more in my Isthmus series on the ups and down of UW-Madison’s efforts to popularize cutting-edge research. This online-only story illustrates the campus’ hands-off policy towards participating in industry-sponsored research.

In this story I looked at an example: The Waisman Center’s pointed refusal to work with the Dane County biotech startup Stemina Biomarker Discovery in its search for a blood test to identify children with Autism Spectrum Disorder.

In contrast to Waisman, eight other clinical sites, including the University of California-Davis, the Children’s Hospital of Philadelphia and Vanderbilt University in Nashville, agreed to conduct  Stemina’s testing.

I report that the early findings of the $8 million study are promising. Certain expressions of autism spectrum disorder could be identified by a blood test.

I write:

This holds the promise of earlier diagnoses and treatment geared to a child’s biology, [Stemina co-funder Elizabeth] Donley says. She told the tech website Xconomy Wisconsin that Stemina’s business division will begin shipping the test to “early adopter” laboratories before the end of the year.

Donley is bullish. “The CAMP study is going to change the way kids are diagnosed. It’s a big deal,” she told me.

[The Waisman Center’s Albee] Messing is not impressed. When I contacted him in August, he sent me a statement that he said represented his thinking as well as the judgment of the Waisman Center and UW Health:

“We share the goal of developing diagnostic methods that allow early identification of individuals at risk for these disorders. However, the approach advocated by Stemina Biomarker, Inc., a for-profit company that necessarily combines scientific and commercial interests, is not one that the scientists at the Waisman Center believe to be valid.”

Donley was furious.

She emailed Messing, copying the chancellor and others: “You know nothing about our approach because you never looked at it. You know nothing about our .. study because you never participated in it. You know nothing about the results or what we’ve accomplished because you’ve never seen them.”

There were more fireworks and also a retracted statement from Messing. To read more, please go here.

UW-Madison’s Research Challenge

November 9, 2018

I’m late in posting the stories I’ve written for Isthmus on UW-Madison’s struggles as a great research university to get its inventions and discoveries into the broader world.  Here’s how the first story begins:

It’s a story that Madison loves to hear.

Two plucky entrepreneurs, Kevin Conroy and Manesh Arora, are hired in 2009 to revive a moribund health-tech startup in Boston. They have the temerity to move it from the best-known metropolis in the country for medical innovation to the much smaller Madison, where Conroy had run Third Wave Technologies. Their company had but two employees.

“Without the UW-Madison, Exact Sciences would not be in Madison,” Conroy says flatly. “We came here because the UW’s biochemistry program is one of the top in the country. It enabled us to hire really strong Ph.D. level scientists.”

Flash forward nine years: Exact Sciences has about 1,600 employees, 200 job vacancies, a stock market valuation of around $8 billion, and a fast-selling non-invasive colorectal cancer test called Cologuard. Other cancer tests are in the works.

Exact Sciences personifies the rise of the new Madison. It rides a wave of tech innovation that is closely tied to the UW’s fabled research prowess. But Cologuard was not tested at UW Hospital and Clinics, as you might expect, but at Mayo Clinics, which is Exact Sciences’ long-time partner. Exact’s other medical trials were conducted at MD Anderson Cancer Center in Houston.

Three years ago, when I wrote a mostly upbeat Isthmus cover story on technology transfer at UW-Madison, Conroy was a brooding presence. Doing clinical trials with the UW School of Medicine and Public Health was just too complicated, too prone for delay with the clinical trial review board, he complained. Both Anderson and Mayo were easier to work with “for a company operating at the speed of light.”

Conroy was heard. Exact Sciences is now doing preparatory research with the UW med school, but not yet a full-blown federally approved clinical trial.

Conroy sees progress. He considers himself a UW-Madison booster. But his impatience remains, and he’s definitely not alone in feeling the campus doesn’t yet have its act together on embracing the 21st century innovation economy. “C’mon, we can do better,” he says, sounding like a football coach at half-time.

To read more, please go here. And while you’re at it keep an eye out for other stories in the series.

A Better Wisconsin Growth Strategy

October 25, 2017

I wound up writing two Isthmus cover stories on the Wisconsin economy. In the first piece I detailed how our recovery was starkly incomplete. Sure, the overall economy led by Dane County had bounced back from the Great Recession. But too many of us were ignoring a less pleasant reality: There is is a broad swath of  economic “left-behinds” in rural Wisconsin and inner-city Milwaukee.

My second story outlines an economic strategy that could turn things around.

The problem is that the state’s commitment to manufacturing, even with its smart nod to high-skilled manufacturing, is one-sided and overwhelming. Part and parcel of the yesteryear economics that holds up the chimera of mining as the savior of northern Wisconsin.

And consider that the Foxconn package is the costliest manufacturing subsidy project in Wisconsin history by a factor at least 10. And that payback in new taxes generated by Foxconn, assuming the campus develops as proposed, won’t come until many of us are dead and buried. No less than in 2043, according to the Legislative Fiscal Bureau….

Here’s the point: Government does best when it sticks to the basics. Infrastructure! Education. Transportation. Safety. Health. Parks. And if it does incentivize certain economic behaviors government should do so carefully and in a way that provides public good and not private payoff.

And there has to be a vision. Or as hockey legend Wayne Gretzky famously put it, you need to skate “to where the puck is going to be, not where it has been.” That isn’t happening. Wisconsin tenaciously holds on to the economics of nostalgia.

You can find the details here:

You Must Remember This, cont’d

January 22, 2017

In December 2013, I wrote about a Madison biotech company facing an investigation from the Food and Drug Administration over a dietary supplement that supposedly bolsters memory recall. Three years later, Quincy Bioscience has been sued by the Federal Trade Commission and the New York attorney  general on a related complaint.

My Isthmus story begins:

Quincy Bioscience, a Madison biotech company that has struck gold in the dietary supplement business, is facing a potentially ruinous lawsuit filed by government regulators.

The Federal Trade Commission in conjunction with the New York state attorney general is seeking to shut down sales of Prevagen, which is a costly over-the-counter supplement the company says improves brain function, including memory.

The supplement’s key ingredient is a synthetic version of a jellyfish protein called aequorin. Quincy has patented it and promoted aequorin as supporting a sharper mind and clearer thinking.

“A clear-cut fraud” is how New York Attorney General Eric Schneiderman described the supplement in a press release. Through its advertising and TV infomercials, Quincy was preying on vulnerable senior citizens, he said, adding: Prevagen is a product “that costs more than a week’s groceries, but provides none of the health benefits that it claims.”

The FTC and Schneiderman want the court to issue a permanent injunction against the sale of Prevagen — which is Quincy’s core product — and to order the company to refund more than $165 million in Prevagen sales to consumers.

To read more, please go here.

UW Tech Transfer: Challenge and Promise

October 15, 2015

Few things are as important for energizing the listless Wisconsin economy than capitalizing on the great research conducted at UW-Madison. I write in this Isthmus cover story:

A game-changer is what UW-Madison sorely needs. Historically one of the nation’s leading research schools, the campus secures more than $1 billion a year in research grants. Yet between 2009 and 2014, Wisconsin ranked 42nd among the states in patents issued, according to federal data. And we were dead last in a survey of entrepreneurial activity taken by the Ewing Marion Kauffman Foundation.

Reality is that despite Dane County’s tech-led boom, the Wisconsin economy is in parlous condition. The state suffered the largest percentage decline of middle-class households in the nation between 2000 and 2013, according to a Pew Charitable Trusts study. Median Wisconsin household income in this period dropped from $60,344 to $51,467 in inflation-adjusted dollars.

Obvious questions follow: Why isn’t all this UW research igniting a wave of business and tech startups across the state? Why hasn’t the UW dynamo reversed the state’s economic decline?

UW-Madison, it’s fair to say, is feeling the heat.

The hostility of the ruling Republicans at the Capitol is as plain to see as the UW System’s $250 million budget cut and Gov. Scott Walker’s initial plan to gut the Wisconsin Idea, the university’s once sacrosanct pledge that its “beneficent influence” would extend statewide.

But that notion of “the boundaries of campus are the boundaries of the state” draws a sharp retort from skeptics who think UW-Madison’s reach seems to abruptly end at the Dane County line. Local folks may be proud that Dane County claims 73% of the new jobs created in Wisconsin over the last 10 years, but outstate observers see this as evidence of how UW-Madison beneficence is highly parochial.

Enter UW-Madison’s Discovery To Product program. I write how this bootcamp for campus entrepreneurs has nurtured a potential breakout campus discovery. Researchers Mark Cook and Jordan Sand have come up with a technique that could dramatically reduce the pervasive  use of human antibiotics in animal feed. That farm industry practice is blamed for producing deadly drug-resistant superbugs.

To read more about their discovery and the complaints that insiders make about UW-Madison’s hostility towards commercializing research, please go here.

Advice For Democrats

April 6, 2015

David Haynes’ column in the Milwaukee Journal Sentinel got me thinking about the need for political realignment in Wisconsin. The paper’s editorial page editor recounted the dismal electoral standing of the Wisconsin Democratic Party and argued the faltering Dems need to rethink and rebuild their party.

I offer my two cents in a guest column in the Journal Sentinel:

First, dial back the vitriol. The hatred and contempt [the Democrats] show for Gov. Scott Walker has been repudiated by the voters. Instead, they should stick to the issues. Look to the future. Embrace the millennials. Champion the tech sector. Celebrate start-ups and entrepreneurs. Support the Ubers of the sharing economy. Get real about unions. Give tough love (and financial support) to public education. Welcome immigrants. Offer a helping hand to the poor.

Most of all, accept the necessity of change. Wisconsin hasn’t. Too often, our political and economic leaders act as if they’re historical re-enactors at Old World Wisconsin. They refight the old battles when the world — and the economy — has moved on.

I made many of these points in a story (see below) that appeared earlier in Isthmus. To read more of my Journal Sentinel piece, please go here.

Old School Politics And The New Economy

March 19, 2015

The disconnection between Wisconsin’s growing tech sector and the state’s governing political dynamic has never been greater. This Isthmus story discusses how the Legislature’s decision to enact union-breaking “right to work” legislation left Madison area tech leaders puzzled and dismayed.

“As an employer, I can tell you this has zero bearing on my decision to stay in Wisconsin or to hire more people,” Dan Wilson, a founder of Moxe Health, told me. Other leaders had similar comments.

I write:.

It’s tempting to dismiss the comments of the techie execs as inconsequential because they represent startups and boutique businesses with small workforces. They are midgets compared to the titans of Wisconsin industry who have promoted right-to-work through their powerful lobbying arm, Wisconsin Manufacturers & Commerce.

But ignoring the new kids is a big mistake.

“In every single state, in every single metro area, young firms create the most jobs. That’s true everywhere,” says Dane Stangler, vice president of research and policy at the Ewing Marion Kauffman Foundation, which advocates for startup businesses.

The tech component has certainly paid off in Dane County.

It’s fueled, of course, by homegrown Epic and its rise as the dominant electronic health records vendor in the country. The workforce tops 8,000. Revenue in 2014 reportedly hit $1.8 billion. And because founder Judith Faulkner insists on running the entire operation through its fairyland campus in Verona, the region has boomed economically. Epic alone accounted for 27% of all the new jobs created here from 2001 to 2012, according to Kennelly.

The city staffer’s presentation on the Madison area’s economic dynamics makes a persuasive case that the Dane County metro area is impressively outperforming the rest of the state. With 10% of the state’s population, Dane County accounts for 12% of the state’s jobs, 15% of its economic output and 16% of the businesses created since 2000 and 73% of the net new jobs created in Wisconsin between 2004 and 2014.

The Milwaukee Journal Sentineldiced the numbers in a different fashion and came to the same conclusion: Dane County led the state in job creation between 2003 and 2013, with nearly 20,000 new jobs. That’s three times as many as second-place Waukesha County. Milwaukee County lost 19,000 jobs in the same period.

For anyone who still sees Madison as a cossetted government town — well, they need to think again. Kennelly’s report shows that the private sector is driving job and wealth creation in Dane County. “Our government workforce is effectively flat,” he says.

Even better, the growing industries here support good-paying jobs, namely in the biomedical/biotechnical and information technology business clusters.

“The Madison area is really an economic engine for Wisconsin,” Kennelly says. “State policymakers sometimes like to pick on Madison. A more constructive approach would be to say: ‘What are they doing right, and how can we replicate it in other parts of the state?'”

To read more, please go here.

Good News For Health IT?

March 19, 2015

If Madison and Dane County ever rise to a top ten metro area for technology, the driver will almost certainly be the growth of health-related technology companies led by former employees of  Epic Systems, the  Verona-headquartered leader in electronic health records.

It’s a good bet that Madison-area software writers, many of them bright Epic expats, jumped up pumping their fists when they read that Epic would shortly launch the “App Exchange” and “open the floodgates” to developers, as pioneer Madison tech entrepreneur Mark Bakken told the Wisconsin State Journal.

Bakken compared the App Exchange to Apple’s wildly successful App Store.

This was huge news. For all the good Epic has done for the Dane County community, it has shown steely indifference to the local health IT industry. The company’s intense focus on serving its worldwide 315 customers has never included playing Big Sister to expats dreaming of devising health software to piggyback onto the company’s proprietary system.

Bakken begged off from further commenting on the App Exchange, emailing, “My hands are tied on anything related to this and Epic in general right now.” Epic spokesman Shawn Kiesau also declined to comment.

But Bakken may have been overly exuberant in his prediction. A local tech leader, who asked for anonymity for business reasons, says Epic insiders say it’s a misnomer to compare Epic’s soon-to-launch App Exchange with Apple’s App Store.

To read more,  please go here.

This longer related story appeared in the same issue of Isthmus.

Epic’s Long Reach

December 5, 2014

Writing about software giant Epic Systems in its hometown is always interesting and always a challenge. The company is famously reclusive, and its former employees, who are at the heart of the Madison area’s emerging health IT industry, are afraid to say anything that might offend the powerful tech company.

In this story for Isthmus, I tease out the controversy over Epic’s noncompete policy for those expats.

The Huron Consulting Group’s announcement in April that it was buying Vonlay, a 130-person Epic-specialty consulting company, set off alarms locally when it became known than Epic had successfully intervened at the 11th hour to insist that Huron not hire Epic employees within two years of them leaving the company.

The one-year separation that Vonlay leaders observed in their hiring would be doubled for the acquiring firm. It also seemingly meant that former Epic employees who had signed an employment contract with a one-year noncompete clause when they had started at Epic would now be subject to a two-year stipulation they hadn’t agreed to.

Huron and Vonlay officials did not respond to queries, but Epic spokesman Brian Spranger confirmed that Huron had agreed to a two-year noncompete term. And then the shocker: “This is being reverted to a one-year term.” Spranger offered no explanation in his email for the reversal. “We’d rather not comment on the policy as a whole.”

There is no shortage of speculation. Most of it circles around Epic fearing it might be treading on federal antitrust laws and being accused of anti-competitive business practices.

To read more, please go here.


%d bloggers like this: